Description
The life sciences industry closed 2004 with a robust fourth quarter. The industry demonstrated its vitality by attracting more than $10 billion in financing, owing mostly to a thoroughly rebounded deb...(more)
Description
This report from Frost & Sullivan tracks the causes behind the strong growth in recent years, and provides a detailed overview of the prevailing trends and competitive strategies in the industry. New...(more)
Description
Soon, rapidly advancing minimally invasive and non-invasive glucose monitoring will combine with novel drug delivery techniques to completely transfigure the diabetes market, and almost triple its val...(more)
Description
Beyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation de...(more)
Description
This report analyzes the worldwide markets for First Aid Kits in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America an...(more)
Description
This report from Packaged Facts analyzes the booming U.S. market for home medical tests. Improvements in technology are providing excitement in this market as new tests are developed and older tests a...(more)
Description
The U.S. Market for First Aid and Sports Medicine Products
This updated Packaged Facts report covers the nearly $3 billion U.S. market for first aid and sports medicine products, focusing on the incre...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
This report analyzes the worldwide markets for Human Reproductive Technologies in US$ Million. The major product segments analyzed are Fertility Enhancement Drugs, Fertility Technologies & Procedures,...(more)
Description
This event will provide you with a competitive assessment of the key diagnostic testing markets, including updates in major market trends and forecasts and the chance to hear case studies exploring ke...(more)
Description
In This Issue…Aside from biotechnology’s continued hot streak on Wall Street, the fourth quarter was a quiet one for the life sciences industry, which raised only $6.4 billion in financings...(more)
Description
Effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity and allow earlier stop/go decisions to be made, eliminating waste o...(more)
Description
Technology Transfer is an important stage for any Pharmaceutical or Biotech company, SMi recognises this is and is proud to announce its inaugural conference Technology Transfer in the Pharmaceutical ...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
REPORT HIGHTLIGHTS
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition:
Description
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
STUDY OVERVIEW
Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly
Description
The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
The focus of the report is on partnerships for busin...(more)
Description
Designing Effective Brand Teams: Brand Governance and Brand Team Management” explores how high-performing brand teams coordinate, communicate, and execute critical activities to drive brand grow...(more)
Description
In 2006, the European neurosurgical and neurointerventional products market totaled approximately $338.9 million, with neurointerventional products accounting for 39.2% of sales; followed by image-gui...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
